PR interval and the response to enzyme-replacement therapy for Fabry's disease.
Waldek
Stephen
S
D015415:Biomarkers; D004562:Electrocardiography / Q000187:drug effects*; D000795:Fabry Disease / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000494:pharmacology* / Q000627:therapeutic use; D008875:Middle Aged; D000519:alpha-Galactosidase / Q000494:pharmacology* / Q000627:therapeutic use
D015415:Biomarkers; D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta